Anti-CD3 antibodies and uses thereof | Patent Publication Number 20200048349

US 20200048349 A1
Patent NumberUS 11603405 B2
Application Number16418082
Filled DateMay 21, 2019
Priority DateMay 24, 2018
Publication DateFeb 13, 2020
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsRonan MCDAID
Bradley HEIDRICH
Ronan McDaid
Colleen Kane
Jennifer NEMETH-SEAY
Chichi Huang
Francois GAUDET
Jill Giles-Komar
Francois Gaudet
Chichi HUANG
Jill GILES-KOMAR
Jennifer Nemeth-Seay
Colleen KANE
Bradley Heidrich
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.